Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Research), By End use (Hospitals & Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Immunohistochemistry Market Growth & Trends
The global immunohistochemistry market size is estimated to reach USD 3.50 billion by 2030, registering to grow at a CAGR of 6.93% from 2025 to 2030 according to a new report by Grand View Research, Inc. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.
The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.
Immunohistochemistry Market Report Highlights
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Danaher Corporation
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
Bio SB
Agilent Technologies, Inc.
Abcam Limited.
Immunohistochemistry Market Growth & Trends
The global immunohistochemistry market size is estimated to reach USD 3.50 billion by 2030, registering to grow at a CAGR of 6.93% from 2025 to 2030 according to a new report by Grand View Research, Inc. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.
The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.
Immunohistochemistry Market Report Highlights
- The antibodies product segment led the market in 2024 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
- The diagnostics application segment led the market in 2024 owing to the widespread application of IHC tests in diagnostic settings
- The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
- The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2024. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
- North America emerged as the largest regional market in 2024 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
- The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country’s market growth
- Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Danaher Corporation
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
Bio SB
Agilent Technologies, Inc.
Abcam Limited.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNOHISTOCHEMISTRY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunohistochemistry Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNOHISTOCHEMISTRY MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Antibodies
4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Primary Antibodies
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Secondary Antibodies
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Equipment
4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Slide Staining System
4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Tissue Microarrays
4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Tissue Processing Systems
4.4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Slide Scanners
4.4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Reagents
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Histological stains
4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Blocking Sera and Reagents
4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Chromogenic Substrates
4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Fixation Reagents
4.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.6. Stabilizers
4.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.7. Organic Solvents
4.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.8. Proteolytic Enzymes
4.5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.9. Diluents
4.5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Kits
4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. IMMUNOHISTOCHEMISTRY MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
5.3. Diagnostics
5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Cancer
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Infectious Diseases
5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Cardiovascular Diseases
5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Autoimmune Diseases
5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Diabetes Mellitus
5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Nephrological Diseases
5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Research
5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. IMMUNOHISTOCHEMISTRY MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospitals & Diagnostic Laboratories
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Institutes
6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. IMMUNOHISTOCHEMISTRY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. F. Hoffmann-La Roche Ltd.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Danaher Corporation
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. PerkinElmer Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bio-Rad Laboratories, Inc.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Cell Signaling Technology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Bio SB
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Agilent Technologies, Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Abcam Limited.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNOHISTOCHEMISTRY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunohistochemistry Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNOHISTOCHEMISTRY MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Antibodies
4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Primary Antibodies
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Secondary Antibodies
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Equipment
4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Slide Staining System
4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Tissue Microarrays
4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Tissue Processing Systems
4.4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Slide Scanners
4.4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Reagents
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Histological stains
4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Blocking Sera and Reagents
4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Chromogenic Substrates
4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Fixation Reagents
4.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.6. Stabilizers
4.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.7. Organic Solvents
4.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.8. Proteolytic Enzymes
4.5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.9. Diluents
4.5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Kits
4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. IMMUNOHISTOCHEMISTRY MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
5.3. Diagnostics
5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Cancer
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Infectious Diseases
5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Cardiovascular Diseases
5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Autoimmune Diseases
5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Diabetes Mellitus
5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Nephrological Diseases
5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Research
5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. IMMUNOHISTOCHEMISTRY MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospitals & Diagnostic Laboratories
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Institutes
6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. IMMUNOHISTOCHEMISTRY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. F. Hoffmann-La Roche Ltd.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Danaher Corporation
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. PerkinElmer Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bio-Rad Laboratories, Inc.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Cell Signaling Technology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Bio SB
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Agilent Technologies, Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Abcam Limited.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global Immunohistochemistry market, by region, 2018 - 2030 (USD Million)
Table 3 Global Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 4 Global Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 5 Global Immunohistochemistry market, by End use, 2018 - 2030 (USD Million)
Table 6 North America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 7 North America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 8 North America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 9 North America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 23 UK Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 24 UK Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 25 UK Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 26 Germany Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 27 Germany Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 28 Germany Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 29 France Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 30 France Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 31 France Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 45 Norway Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 52 Japan Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 53 Japan Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 54 China Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 55 China Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 56 China Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 57 India Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 58 India Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 59 India Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 61 Australia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 62 Australia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 63 South Korea Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 71 Latin America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 80 MEA Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 81 MEA Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 82 MEA Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 90 UAE Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 91 UAE Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global Immunohistochemistry market, by region, 2018 - 2030 (USD Million)
Table 3 Global Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 4 Global Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 5 Global Immunohistochemistry market, by End use, 2018 - 2030 (USD Million)
Table 6 North America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 7 North America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 8 North America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 9 North America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 23 UK Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 24 UK Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 25 UK Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 26 Germany Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 27 Germany Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 28 Germany Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 29 France Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 30 France Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 31 France Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 45 Norway Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 52 Japan Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 53 Japan Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 54 China Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 55 China Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 56 China Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 57 India Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 58 India Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 59 India Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 61 Australia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 62 Australia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 63 South Korea Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 71 Latin America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 80 MEA Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 81 MEA Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 82 MEA Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 90 UAE Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 91 UAE Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Immunohistochemistry market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Immunohistochemistry market: Product outlook key takeaways
Fig. 20 Immunohistochemistry market: Product movement analysis
Fig. 21 Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Primary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Secondary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Slide Staining System market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Tissue Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Tissue Processing Systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Slide Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Histological stains market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Blocking Sera and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Chromogenic Substrates market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Fixation Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Stabilizers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Organic Solvents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Proteolytic Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Diluents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Immunohistochemistry market: Application outlook key takeaways
Fig. 41 Immunohistochemistry market: Application movement analysis
Fig. 42 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Cardiovascular Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Diabetes Mellitus market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Nephrological Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Immunohistochemistry market: End-use outlook key takeaways
Fig. 52 Immunohistochemistry market: End use movement analysis
Fig. 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Regional marketplace outlook, 2024 & 2030 (USD million)
Fig. 57 Regional marketplace: Key takeaways
Fig. 58 North America Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 U.S. Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Canada Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Mexico Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Europe Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 UK Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Germany Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 France Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Spain Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Italy Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Denmark Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Sweden Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Norway Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Japan Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 China Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 India Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Australia Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Korea Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Thailand Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Market participant categorization
Fig. 97 Immunohistochemistry market position analysis, 2024
Fig. 98 Strategic framework
Fig. 1 Immunohistochemistry market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Immunohistochemistry market: Product outlook key takeaways
Fig. 20 Immunohistochemistry market: Product movement analysis
Fig. 21 Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Primary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Secondary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Slide Staining System market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Tissue Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Tissue Processing Systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Slide Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Histological stains market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Blocking Sera and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Chromogenic Substrates market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Fixation Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Stabilizers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Organic Solvents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Proteolytic Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Diluents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Immunohistochemistry market: Application outlook key takeaways
Fig. 41 Immunohistochemistry market: Application movement analysis
Fig. 42 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Cardiovascular Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Diabetes Mellitus market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Nephrological Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Immunohistochemistry market: End-use outlook key takeaways
Fig. 52 Immunohistochemistry market: End use movement analysis
Fig. 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Regional marketplace outlook, 2024 & 2030 (USD million)
Fig. 57 Regional marketplace: Key takeaways
Fig. 58 North America Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 U.S. Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Canada Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Mexico Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Europe Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 UK Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Germany Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 France Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Spain Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Italy Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Denmark Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Sweden Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Norway Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Japan Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 China Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 India Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Australia Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Korea Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Thailand Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Market participant categorization
Fig. 97 Immunohistochemistry market position analysis, 2024
Fig. 98 Strategic framework
